Identification of Genes from the Fungal Pathogen Cryptococcus neoformans Related to Transmigration into the Central Nervous System

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Tseng, Hsiang Kuang ^a,b,f   Liu, Chang Pan ^a   Price, Michael S ^c   Jong, Ambrose Y ^d   Chang, Jui Chih ^e   Toffaletti, Dena L ^c   Betancourt Quiroz, Marisol ^c   Frazzitta, Aubrey E ^c   Cho, Wen Long ^a,f   Perfect, John R ^c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b MACKAY MEMORIAL HOSPITAL   (Taiwan)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^f MACKAY MEDICAL COLLEGE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; NOURSEOTHRICIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; FEMALE; FNX1 GENE; FUNGAL GENE; FUNGUS IDENTIFICATION; FUNGUS MUTANT; GENE IDENTIFICATION; GENE MUTATION; HUMAN; HUMAN CELL; MACROPHAGE; MENINGOENCEPHALITIS; MOUSE; NONHUMAN; PATHOGENESIS; PHAGOCYTOSIS; RUB1 GENE; TRANSCELLULAR CELL MIGRATION;

ACETYLTRANSFERASES; ANIMALS; BLOOD-BRAIN BARRIER; CELL ADHESION; CENTRAL NERVOUS SYSTEM; CRYPTOCOCCUS NEOFORMANS; ENDOTHELIAL CELLS; GENES, FUNGAL; GENETIC ASSOCIATION STUDIES; GENETIC TESTING; MICE; MICROVESSELS; MODELS, BIOLOGICAL; MUTATION; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; TEMPERATURE; TRANSCYTOSIS; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION;

EQUIDAE; FILOBASIDIELLA NEOFORMANS;

EID: 84866689850     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045083     Document Type: Article

References (46)

1. Chayakulkeeree M, Perfect JR (2006) Cryptococcosis. Infect Dis Clin North Am 20: 507-544, v-vi.doi: 10.1016/j.idc.2006.07.001.
2. Jarvis JN, Dromer F, Harrison TS, Lortholary O, (2008) Managing cryptococcosis in the immunocompromised host. Curr Opin Infect Dis 21: 596-603 doi: 10.1097/QCO.0b013e3283177f6c.
3. Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, et al. (2009) Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 23: 525-530 doi: 10.1097/QAD.0b013e328322ffac.
4. Harrison TS, (2009) The burden of HIV-associated cryptococcal disease. AIDS 23: 531-532 doi: 10.1097/QAD.0b013e328322ffc3.
5. Chretien F, Lortholary O, Kansau I, Neuville S, Gray F, et al. (2002) Pathogenesis of cerebral Cryptococcus neoformans infection after fungemia. J Infect Dis 186: 522-530 doi: 10.1086/341564.
6. Shi M, Li SS, Zheng C, Jones GJ, Kim KS, et al. (2010) Real-time imaging of trapping and urease-dependent transmigration of Cryptococcus neoformans in mouse brain. J Clin Invest 120: 1683-1693 doi: 10.1172/JCI41963.
7. Charlier C, Chretien F, Baudrimont M, Mordelet E, Lortholary O, et al. (2005) Capsule structure changes associated with Cryptococcus neoformans crossing of the blood-brain barrier. Am J Pathol 166: 421-432 doi: 10.1016/S0002-9440(10)62265-1.
8. Toffaletti DL, Rude TH, Johnston SA, Durack DT, Perfect JR, (1993) Gene transfer in Cryptococcus neoformans by use of biolistic delivery of DNA. J Bacteriol 175: 1405-1411.
9. Perfect JR, (2005) Cryptococcus neoformans: a sugar-coated killer with designer genes. FEMS Immunol Med Microbiol 45: 395-404 doi: 10.1016/j.femsim.2005.06.005.
10. Saenz HL, Dehio C, (2005) Signature-tagged mutagenesis: technical advances in a negative selection method for virulence gene identification. Curr Opin Microbiol 8: 612-619 doi: 10.1016/j.mib.2005.08.013.
11. Loftus BJ, Fung E, Roncaglia P, Rowley D, Amedeo P, et al. (2005) The genome of the basidiomycetous yeast and human pathogen Cryptococcus neoformans. Science 307: 1321-1324 doi: 10.1126/science.1103773.
12. Liu OW, Chun CD, Chow ED, Chen C, Madhani HD, et al. (2008) Systematic genetic analysis of virulence in the human fungal pathogen Cryptococcus neoformans. Cell 135: 174-188 doi: 10.1016/j.cell.2008.07.046.
13. Alonso-Monge R, Navarro-Garcia F, Roman E, Eisman B, Nombela C, et al. (2003) Strategies for the identification of virulence determinants in human pathogenic fungi. Curr Genet 42: 301-312 doi: 10.1007/s00294-002-0364-1.
14. Chen SH, Stins MF, Huang SH, Chen YH, Kwon-Chung KJ, et al. (2003) Cryptococcus neoformans induces alterations in the cytoskeleton of human brain microvascular endothelial cells. J Med Microbiol 52: 961-970.
15. Chang YC, Stins MF, McCaffery MJ, Miller GF, Pare DR, et al. (2004) Cryptococcal yeast cells invade the central nervous system via transcellular penetration of the blood-brain barrier. Infect Immun 72: 4985-4995 doi: 10.1128/IAI.72.9.4985-4995.2004.
16. Olszewski MA, Noverr MC, Chen G-H, Toews GB, Cox GM, et al. (2004) Urease Expression by Cryptococcus neoformans Promotes Microvascular Sequestration, Thereby Enhancing Central Nervous System Invasion. The American Journal of Pathology 164: 1761-1771 doi: 10.1016/s0002-9440(10)63734-0.
17. Charlier C, Nielsen K, Daou S, Brigitte M, Chretien F, et al. (2009) Evidence of a role for monocytes in dissemination and brain invasion by Cryptococcus neoformans. Infect Immun 77: 120-127 doi: 10.1128/IAI.01065-08.
18. Jong A, Wu CH, Shackleford GM, Kwon-Chung KJ, Chang YC, et al. (2008) Involvement of human CD44 during Cryptococcus neoformans infection of brain microvascular endothelial cells. Cell Microbiol 10: 1313-1326 doi: 10.1111/j.1462-5822.2008.01128.x.
19. Chang YC, Jong A, Huang S, Zerfas P, Kwon-Chung KJ, (2006) CPS1, a homolog of the Streptococcus pneumoniae type 3 polysaccharide synthase gene, is important for the pathobiology of Cryptococcus neoformans. Infect Immun 74: 3930-3938 doi: 10.1128/IAI.00089-06.
20. Jong A, Wu CH, Chen HM, Luo F, Kwon-Chung KJ, et al. (2007) Identification and Characterization of CPS1 as a Hyaluronic Acid Synthase Contributing to the Pathogenesis of Cryptococcus neoformans Infection. Eukaryot Cell 6: 1486-1496 doi: 10.1128/ec.00120-07.
21. Lee A, Toffaletti DL, Tenor J, Soderblom EJ, Thompson JW, et al. (2010) Survival defects of Cryptococcus neoformans mutants exposed to human cerebrospinal fluid result in attenuated virulence in an experimental model of meningitis. Infect Immun 78: 4213-4225 doi: 10.1128/IAI.00551-10.
22. Moyrand F, Fontaine T, Janbon G, (2007) Systematic capsule gene disruption reveals the central role of galactose metabolism on Cryptococcus neoformans virulence. Mol Microbiol 64: 771-781 doi: 10.1111/j.1365-2958.2007.05695.x.
23. Hull CM, Cox GM, Heitman J, (2004) The alpha-specific cell identity factor Sxi1alpha is not required for virulence of Cryptococcus neoformans. Infect Immun 72: 3643-3645 doi: 10.1128/IAI.72.6.3643-3645.2004.
24. Cox GM, Mukherjee J, Cole GT, Casadevall A, Perfect JR, (2000) Urease as a virulence factor in experimental cryptococcosis. Infect Immun 68: 443-448.
25. Okagaki LH, Wang Y, Ballou ER, O'Meara TR, Bahn YS, et al. (2011) Cryptococcal titan cell formation is regulated by G-protein signaling in response to multiple stimuli. Eukaryot Cell 10: 1306-1316 doi: 10.1128/EC.05179-11.
26. Okagaki LH, Strain AK, Nielsen JN, Charlier C, Baltes NJ, et al. (2010) Cryptococcal cell morphology affects host cell interactions and pathogenicity. PLoS Pathog 6: e1000953 doi: 10.1371/journal.ppat.1000953.
27. Bava AJ, Negroni R, Bianchi M, (1993) Cryptococcosis produced by a urease negative strain of Cryptococcus neoformans. J Med Vet Mycol 31: 87-89.
28. Ruane PJ, Walker LJ, George WL, (1988) Disseminated infection caused by urease-negative Cryptococcus neoformans. J Clin Microbiol 26: 2224-2225.
29. Wada Y, Ohsumi Y, Anraku Y, (1992) Genes for directing vacuolar morphogenesis in Saccharomyces cerevisiae. I. Isolation and characterization of two classes of vam mutants. J Biol Chem 267: 18665-18670.
30. Stolinski LA, Eisenmann DM, Arndt KM, (1997) Identification of RTF1, a novel gene important for TATA site selection by TATA box-binding protein in Saccharomyces cerevisiae. Mol Cell Biol 17: 4490-4500.
31. Alspaugh JA, Cavallo LM, Perfect JR, Heitman J, (2000) RAS1 regulates filamentation, mating and growth at high temperature of Cryptococcus neoformans. Mol Microbiol 36: 352-365.
32. Jong A, Wu C-H, Prasadarao NV, Kwon-Chung KJ, Chang YC, et al. (2008) Invasion of Cryptococcus neoformans into human brain microvascular endothelial cells requires protein kinase C-α activation. Cell Microbiol 10: 1854-1865 doi: 10.1111/j.1462-5822.2008.01172.x.
33. Huang SH, Long M, Wu CH, Kwon-Chung KJ, Chang YC, et al. (2011) Invasion of Cryptococcus neoformans into human brain microvascular endothelial cells is mediated through the lipid rafts-endocytic pathway via the dual specificity tyrosine phosphorylation-regulated kinase 3 (DYRK3). J Biol Chem 286: 34761-34769 doi: 10.1074/jbc.M111.219378.
34. Jong A, Wu CH, Gonzales-Gomez I, Kwon-Chung KJ, Chang YC, et al. (2012) Hyaluronic acid receptor CD44 deficiency is associated with decreased Cryptococcus neoformans brain infection. J Biol Chem 287: 15298-15306 doi: 10.1074/jbc.M112.353375.
35. Dimitrov K, Sazer S, (1998) The role of fnx1, a fission yeast multidrug resistance protein, in the transition of cells to a quiescent G0 state. Mol Cell Biol 18: 5239-5246.
36. Chardwiriyapreecha S, Shimazu M, Morita T, Sekito T, Akiyama K, et al. (2008) Identification of the fnx1+ and fnx2+ genes for vacuolar amino acid transporters in Schizosaccharomyces pombe. FEBS Lett 582: 2225-2230 doi: 10.1016/j.febslet.2008.05.017.
37. Laplaza JM, Bostick M, Scholes DT, Curcio MJ, Callis J, (2004) Saccharomyces cerevisiae ubiquitin-like protein Rub1 conjugates to cullin proteins Rtt101 and Cul3 in vivo. Biochem J 377: 459-467 doi: 10.1042/BJ20030755.
38. McCluskey K, (2003) The Fungal Genetics Stock Center: from molds to molecules. Adv Appl Microbiol 52: 245-262.
39. Chun CD, Liu OW, Madhani HD, (2007) A link between virulence and homeostatic responses to hypoxia during infection by the human fungal pathogen Cryptococcus neoformans. PLoS Pathog 3: e22 doi: 10.1371/journal.ppat.0030022.
40. Pitkin JW, Panaccione DG, Walton JD, (1996) A putative cyclic peptide efflux pump encoded by the TOXA gene of the plant-pathogenic fungus Cochliobolus carbonum. Microbiology 142 (Pt 6): 1557-1565.
41. Velegraki A, Kambouris M, Kostourou A, Chalevelakis G, Legakis NJ, (1999) Rapid extraction of fungal DNA from clinical samples for PCR amplification. Med Mycol 37: 69-73.
42. del Poeta M, Toffaletti DL, Rude TH, Sparks SD, Heitman J, et al. (1999) Cryptococcus neoformans differential gene expression detected in vitro and in vivo with green fluorescent protein. Infect Immun 67: 1812-1820.
43. Jong AY, Wu CH, Jiang S, Feng L, Chen HM, et al. (2007) HIV-1 gp41 ectodomain enhances Cryptococcus neoformans binding to HBMEC. Biochem Biophys Res Commun 356: 899-905 doi: 10.1016/j.bbrc.2007.03.100.
44. Price MS, Nichols CB, Alspaugh JA, (2008) The Cryptococcus neoformans Rho-GDP dissociation inhibitor mediates intracellular survival and virulence. Infect Immun 76: 5729-5737 doi: 10.1128/IAI.00896-08.
45. Wormley FL Jr, Perfect JR, (2005) Immunology of infection caused by Cryptococcus neoformans. Methods Mol Med 118: 193-198 doi: 10.1385/1-59259-943-5:193.
46. Mukherjee S, Feldmesser M, Casadevall A, (1996) J774 murine macrophage-like cell interactions with Cryptococcus neoformans in the presence and absence of opsonins. J Infect Dis 173: 1222-1231.